Mitomycin-C, Sterile Ophthalmic Solution, Preservative Free, 0.16mg/0.8mL (0.2 mg/mL), 0.8 mL per...

FDA Recall #D-0409-2022 — Class II — December 6, 2021

Recall #D-0409-2022 Date: December 6, 2021 Classification: Class II Status: Terminated

Product Description

Mitomycin-C, Sterile Ophthalmic Solution, Preservative Free, 0.16mg/0.8mL (0.2 mg/mL), 0.8 mL per syringe, Single Use Syringe, For Topical Ophthalmic Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1011-01

Reason for Recall

Lack of Assurance of Sterility

Recalling Firm

Edge Pharma, LLC — Colchester, VT

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

154 syringes

Distribution

nationwide

Code Information

11-2021-08@9 12/18/2021

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated